Zacks Investment Research cut shares of Ampio Pharmaceuticals (NYSEAMERICAN:AMPE – Get Rating) from a hold rating to a strong sell rating in a report published on Friday morning, Zacks.com reports. According to Zacks, “Ampio Pharmaceuticals, Inc. develops proprietary drugs for metabolic disease, eye disease, kidney disease, inflammation, CNS disease, and male sexual dysfunction. Principal products […]